HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER

被引：0

作者：

HEDLEY, D ^{[1
]}

DALGLEISH, A ^{[1
]}

COATES, A ^{[1
]}

FOX, R ^{[1
]}

RAGHAVAN, D ^{[1
]}

TATTERSALL, M ^{[1
]}

机构：

[1] LUDWIG INST CANC RES,SYDNEY CANC THERAPY BRANCH,SYDNEY,AUSTRALIA

来源：

MEDICAL AND PEDIATRIC ONCOLOGY | 1983年 / 11卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 205

页数：1

共 50 条

[31] ORAL HIGH-DOSE OF MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF ADVANCED BREAST AND ENDOMETRIAL CARCINOMA
BERNARDOSTRADA, MR
IMPARATO, E
ASPESI, G
PAVESI, L
DELLACUNA, GR
MINERVA MEDICA, 1980, 71 (44) : 3241 - 3246
[32] HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)
PANNUTI, F
MARTONI, A
FRUET, F
CRICCA, A
CANCER TREATMENT REPORTS, 1979, 63 (07): : 1219 - 1219
[33] CLINICAL-TRIAL OF HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF METASTATIC BREAST-CANCER AND REVIEW OF THE LITERATURE
DAVILA, E
VOGEL, CL
EAST, D
CAIRNS, V
HILSENBECK, S
CANCER, 1988, 61 (11) : 2161 - 2167
[34] CYCLICAL USE OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
GUNDERSEN, S
KVINNSLAND, S
LUNDGREN, S
KLEPP, O
LUND, E
BORMER, O
HOST, H
BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (01) : 45 - 50
[35] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
BLOSSEY, HC
WANDER, HE
KOEBBERLING, J
NAGEL, GA
CANCER, 1984, 54 (06) : 1208 - 1215
[36] ORAL HIGH-DOSE PROGESTINS AS TREATMENT FOR ADVANCED BREAST-CANCER
LUNDGREN, S
KVINNSLAND, S
UTAAKER, E
ACTA ONCOLOGICA, 1989, 28 (06) : 811 - 816
[37] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED OVARIAN-CANCER
QUINN, MA
ROME, RM
GRANT, P
PLANNER, RS
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (05) : 239 - 241
[38] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED BREAST-CANCER
TCHEKMEDYIAN, NS
TAIT, N
ABRAMS, J
AISNER, J
SEMINARS IN ONCOLOGY, 1988, 15 (02) : 44 - 49
[39] WEEKLY DOXORUBICIN WITH OR WITHOUT HIGH-DOSE A MEDROXYPROGESTERONE ACETATE IN HORMONE-RESISTANT ADVANCED BREAST-CANCER - A RANDOMIZED STUDY
GUNDERSEN, S
HANNISDAL, E
LUNDGREN, S
WIST, E
EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1775 - 1778
[40] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) TREATMENT - CORTISOL MPA SERUM PROFILES IN RELATION TO BREAST-CANCER REGRESSION
MAHLKE, M
GRILL, HJ
KNAPSTEIN, P
WIEGAND, U
POLLOW, K
ONCOLOGY, 1985, 42 (03) : 144 - 149

← 1 2 3 4 5 →